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Gain-of-functionDrosophila Polycomb Repressive Complex 2 (PRC2) is a lysine methyltransferase that trimethylates histone
H3 lysine 27 (H3K27me3), a modiﬁcation essential for Polycomb silencing. Mutations in its catalytic subunit,
E(Z), that abolish its methyltransferase activity disrupt Polycomb silencing, causing derepression of Poly-
comb target genes in cells where they are normally silenced. In contrast, the unusual E(z) mutant allele
Trithorax mimic (E(z)Trm) causes dominant homeotic phenotypes similar to those caused by mutations in
trithorax (trx), an antagonist of Polycomb silencing. This suggests that E(z)Trm causes inappropriate silencing
of Polycomb target genes in cells where they are normally active. Here we show that E(z)Trm mutants have an
elevated level of H3K27me3 and reduced levels of H3K27me1 and H3K27me2, modiﬁcations also carried out
by E(Z). This suggests that the E(z)Trm mutation increases the H3K27 trimethylation efﬁciency of E(Z). Acet-
ylated H3K27 (H3K27ac), a mark of transcriptionally active genes that directly antagonizes H3K27 methyla-
tion by E(Z), is also reduced in E(z)Trm mutants, consistent with their elevated H3K27me3 level causing
inappropriate silencing. In 0–4 h E(z)Trm embryos, H3K27me3 accumulates prematurely and to high levels
and does so at the expense of H3K27ac, which is normally present at high levels in early embryos. Despite
their high level of H3K27me3, expression of Abd-B initiates normally in homozygous E(z)Trm embryos, but
is substantially lower than in wild type embryos by completion of germ band retraction. These results suggest
that increased H3K27 trimethylation activity of E(Z)Trm causes the premature accumulation of H3K27me3 in
early embryogenesis, “predestining” initially active Polycomb target genes to silencing once Polycomb silenc-
ing is initiated.
© 2011 Elsevier Inc. All rights reserved.Introduction
The Polycomb group (PcG) proteins were ﬁrst identiﬁed for their
role in the transcriptional silencing of the Drosophila homeotic
genes. During early embryogenesis, the spatially restricted patterns
of homeotic gene expression are initially established by the actions
of transiently expressed transcriptional activators and repressors
encoded by the gap and pair rule segmentation genes (Casares and
Sanchez-Herrero, 1995; Harding and Levine, 1988; Kuziora and
McGinnis, 1988; Reinitz and Levine, 1990), a process that does not re-
quire PcG proteins. By the completion of germ band elongation
(~5.3 h), these transient factors have disappeared and PcG proteins
have become required for subsequent maintenance of repression of
the homeotic genes in cells outside of their spatially restricted ex-
pression domains. In loss-of-function PcG mutants, the homeotic
genes are initially expressed in their normal spatially restricted do-
mains, but they become ectopically derepressed as germ bandSchool of Medicine, 10900 Eu-
432.
anik), peter.harte@case.edu
rights reserved.elongation is completed (Celniker et al., 1989; Kuziora and
McGinnis, 1988; Simon et al., 1992). At the same time, Trithorax
(TRX) and other Trithorax Group (TrxG) proteins become required
to prevent Polycomb silencing and maintain transcriptionally active
states of the homeotic genes in cells where they were initially activat-
ed (Breen and Harte, 1993; Petruk et al., 2001; Sedkov et al., 1994).
Besides the homeotic genes, recent studies have shown that PcG
proteins are also directly required for the repression of hundreds to
thousands of other genes that are involved in a wide variety of biolog-
ical processes, including cell fate determination, stem cell pluripo-
tency, cell growth and proliferation, differentiation, regeneration,
DNA repair, and others (Bracken and Helin, 2009; Conerly et al.,
2011; Margueron and Reinberg, 2011; Martinez and Cavalli, 2006;
Schwartz and Pirrotta, 2007).
More than a dozen PcG proteins have been identiﬁed. Many have
been evolutionarily conserved throughout the animal and plant king-
doms, and their functions in transcriptional silencing have been sim-
ilarly conserved (Margueron and Reinberg, 2011; Schwartz and
Pirrotta, 2007). Several distinct multi-protein PcG complexes have
been characterized, each possessing unique activities (Francis et al.,
2004; Kavi and Birchler, 2009; Klymenko et al., 2006; Lagarou et al.,
2008; Ng et al., 2000; Saurin et al., 2001; Savla et al., 2008;
Fig. 1. Alignment of sequences surrounding the R741K E(Z)Trm mutation in E(Z) ortho-
logs. The SET domain of E(Z) is located in the C-terminal portion of the protein. R741
(highlighted in gray) has been widely conserved in E(Z) homologs from both animal
and plant kingdoms. Examples: plants (A. Thaliana CLF), invertebrates (sea urchin, S.
pupuratus); protochordates (tunicate, Ciona intestinalis); vertebrates (ﬁsh, Zebra
danio) EZH2; mammal (H. sapiens EZH2).
250 V.A. Stepanik, P.J. Harte / Developmental Biology 364 (2012) 249–258Scheuermann et al., 2010; Schuettengruber et al., 2009; Shao et al.,
1999; Tie et al., 2001; Tie et al., 2003). Polycomb Repressive Complex
2 (PRC2) is a lysine methyltransferase that methylates lysine 27 of
histone H3 (H3K27) (Cao et al., 2002; Czermin et al., 2002;
Kuzmichev et al., 2002; Muller et al., 2002). Its catalytic activity re-
sides in the SET domain of its E(Z) subunit. The various members of
the SET domain methyltransferase family differ not only in their spec-
iﬁcity for particular lysines in their polypeptide substrates, but also in
their ability to use unmodiﬁed, mono- and dimethylated lysines as
substrates, and their resultant yields of mono-, di- and trimethylated
products (Cheng and Zhang, 2007).
Methylated H3K27 exists in vivo in mono-, di- and trimethylated
forms. In Drosophila, H3K27me3 has been estimated to comprise
only 5–10% of total H3, while H3K27me2 (50%) and H3K27me1
(10–20%) are considerably more abundant (Ebert et al., 2004). E(Z)
appears to be responsible for all H3K27 di- and trimethylation and
much if not all monomethylation, since loss of E(Z) function results
in loss of H3K27me3, H3K27me2 and H3K27me1 (Cao et al., 2002;
Kurzhals et al., 2008; Tie et al., 2009). Only H3K27me3 is associated
with Polycomb silencing. In embryos and S2 cell lines, H3K27me3 is
distributed in broad domains spanning entire silenced homeotic
genes and other Polycomb-regulated genes (Beisel et al., 2007;
Negre et al., 2006; Schuettengruber et al., 2009; Schwartz et al.,
2006; Schwartz et al., 2010). Deposition of H3K27me3 at the promot-
er regions of target genes may be particularly crucial for silencing,
perhaps serving to recruit another PcG complex, PRC1 (Beisel et al.,
2007; Chopra et al., 2011; Enderle et al., 2011; Mito et al., 2007;
Papp and Muller, 2006; Schuettengruber et al., 2009; Schwartz et
al., 2006, 2010). In E(z) mutant embryos, H3K27 methylation is lost
(Cao et al., 2002), and the homeotic genes are ectopically derepressed
(Jones and Gelbart, 1990; Simon et al., 1992).
Loss-of-function mutations in E(z) and in the genes encoding
other PRC2 subunits (esc, escl, Su(z)12, Pcl) cause characteristic PcG
mutant phenotypes, including transformations of segmental identi-
ties due to ectopic derepression of the homeotic genes. In contrast,
the unusual dominant E(z)mutation Trithorax mimic (E(z)Trm) causes
homeotic phenotypes similar to those caused by mutations in
trithorax (trx), a key antagonist of Polycomb silencing (Bajusz et al.,
2001). In trx mutants, the expression levels of the homeotic genes
are initially normal, but by completion of germ band retraction are
substantially lower than normal in cells where they were initially ac-
tive (Breen and Harte, 1993; Sedkov et al., 1994). This results, at least
in part, from default Polycomb silencing of initially active homeotic
genes, when the anti-silencing activity of TRX is absent (Ingham,
1985; Ingham and Whittle, 1980; Klymenko and Muller, 2004;
Pirrotta et al., 1995). The dominant trx-like phenotypes of E(z)Trm
suggested that it causes inappropriate silencing of Polycomb target
genes in cells where they are normally active (Bajusz et al., 2001), ap-
parently overriding the anti-silencing effects of TRX and other TrxG
proteins. Given that E(Z) is the catalytic subunit of the PRC2 methyl-
transferase complex, we suspected that E(z)Trm might be a hyper-
morph, producing a “hyperactive” mutant enzyme.
The E(z)Trm mutation causes a single amino acid substitution
(R741K) in the catalytic SET domain (Bajusz et al., 2001). This same
mutation has been independently isolated twice, indicating that its
trx-like phenotypes are indeed due to the R741K substitution
(Bajusz et al., 2001). This residue has been highly conserved in E(Z)
orthologs, including those from plants (Fig. 1), arguing that it is likely
to be functionally important. Structural and functional studies of
other SET domain proteins have shown that this region of the SET do-
main contains residues that project into the catalytic pockets of these
enzymes. Some of these residues are invariant in all SET domains
(e.g., Y740) and are critical for catalysis. Others vary among different
SET domain proteins but are conserved among orthologs, including a
so-called “switch” residue (corresponding to F738 in E(Z)), which af-
fects the number of methyl groups each enzyme can add to asubstrate lysine (Collins et al., 2005; Zhang et al., 2003) (see
Discussion). The residue at the position corresponding to R741 has
not been previously implicated in the catalytic activity of any SET do-
main methyltransferase or shown to affect the relative yields of
mono-, di- and tri-methyl reaction products. However, its conserva-
tion and proximity to other catalytically important residues suggest
that the E(Z)Trm protein might have altered methyltransferase activi-
ty and product yields.
Here we report that E(z)Trm mutants have elevated levels of
H3K27me3 and reduced levels of H3K27me2 and H3K27me1. They
also have reduced levels of H3K27ac, an alternative H3K27 modiﬁca-
tion associated with transcriptionally active genes that directly antag-
onizes H3K27 methylation by E(Z) at transcriptionally active
Polycomb target genes. We also show that E(z)Trm mutant embryos
prematurely accumulate high levels of H3K27me3, and do so at the
expense of the H3K27ac normally present in the early embryo.
While Abd-B expression is initiated normally in E(z)Trm embryos,
after completion of germ band elongation the level of ABD-B protein
becomes much lower than in wild type embryos. These results
strongly suggest that the E(Z)Trm mutant enzyme has increased tri-
methylation efﬁciency and that the resulting higher level of
H3K27me3 (and lower level of H3K27ac) is responsible for the dom-
inant trx-like mutant phenotypes of E(z)Trm mutants. We discuss the
implications of the inappropriate silencing of initially active Poly-
comb target genes in this unusual E(z) mutant for the initiation and
regulation of Polycomb silencing in the early embryo.
Results
E(z)Trm affects Abd-B expression in the early embryo
The dominant trx-like phenotypes of E(z)Trm heterozygous adults
include partial transformations of posterior abdominal segment
identities to more anterior segment identities, similar to those
seen in Abd-B mutants. These transformations are more pronounced
in E(z)Trm hemizygotes, which develop into pharate adults, and are
even more extreme in rare pharate adult homozygotes (Bajusz et
al., 2001; data not shown). This increasing severity of mutant pheno-
types with increasing mutant gene dosage is a hallmark of hyperac-
tivity mutants. Since the effect of E(z)Trm on homeotic gene
expression has not been directly determined previously, we ﬁrst ex-
amined the effects of E(z)Trm mutation on ABD-B protein expression
in staged homozygous embryos, which should exhibit the most se-
vere effects.
In wild type embryos, Abd-B transcripts can ﬁrst be detected 2.5 to
3 h after fertilization, prior to completion of cellularization of the
blastoderm (Harding and Levine, 1988; Kuziora and McGinnis,
1988; Reinitz and Levine, 1990). ABD-B protein is ﬁrst detected
around 4 h after fertilization, in stage 9, during germ band elongation,
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Simon et al., 1992). As shown in Fig. 2, in both wild type and homozy-
gous E(z)Trm embryos, ABD-B protein expression becomes detectable
at the same time (at ~4 h) and initially accumulates to comparable
levels. Thus the E(z)Trmmutation does not prevent or perturb the nor-
mal initiation of Abd-B expression in the early embryo. However, by
stage 12, after germ band retraction has begun (>7.2 h), the ABD-B
level is substantially lower in homozygous E(z)Trm embryos than in
wild type embryos (Fig. 2), presumably reﬂecting a change in RNA
levels that began 1–1.5 h earlier, allowing for the time lag between
RNA and protein detection. This is slightly later than ectopic ABD-B
expression is ﬁrst detected in loss-of-function E(z), esc and other
PcG mutant embryos (5–6 h) (Celniker et al., 1989; Kuziora and
McGinnis, 1988; Simon et al., 1992). These observations indicate
that the E(z)Trm mutation does indeed cause inappropriate silencing
of normally active Polycomb target genes, and begins to do so early
in embryogenesis, at about the same time that Polycomb silencing
normally becomes required, but no earlier. Interestingly, the time of
onset of reduced expression in E(z)Trm mutants is remarkably similar
to that of trithorax and CBP mutants, which also exhibit a normal
onset of homeotic gene expression, followed by subsequent decay
after completion of germ band elongation and the onset of Polycomb
silencing (Petruk et al., 2001; Sedkov et al., 1994). This timing thus
suggests that the E(Z)Trm mutant enzyme overrides the normal an-
tagonistic effects of TRX, CBP and other TrxG proteins that become re-
quired at this time to prevent default Polycomb silencing and
maintain the expression of initially active Polycomb target genes
(Pirrotta et al., 1995).E(z)Trm causes a substantial increase in H3K27me3 at the expense of
H3K27me2 and H3K27me1
To investigate the molecular basis of the phenotypes of E(z)Trm mu-
tants, we examined the bulk level of H3K27me3 in extracts of E(z)Trm
mutant adults by quantitative Western analysis. We reasoned that the
location of the R741K substitution, near highly conserved residues
essential for catalysis, might alter the activity of the mutant en-
zyme and the steady state levels of its methyl-H3K27 products.
As shown in Fig. 3A (and Supplemental Fig. 1), the H3K27me3
level in adult E(z)Trm/+heterozygotes, is approximately 2.5 times
that of wild type controls. The E(Z)Trm mutant protein level is in-
distinguishable from that of wild type E(Z) (F. Tie and P. Harte,
data not shown). This suggests that the E(z)Trm mutation alters
the behavior of the mutant enzyme, and also suggests a possible
molecular basis for the phenotypes of E(z)Trm mutants.
Compared to E(z)Trm heterozygotes, E(z)Trm hemizygotes (i.-
e., E(z)Trm/Df), and ﬂies carrying a heteroallelic combination ofFig. 2. ABD-B levels are reduced in E(z)Trm embryos after completion of germ band elongatio
the indicated stages and times. At stages before Polycomb silencing is required, ABD-B leve
following the normal onset of silencing, ABD-B protein is lower in E(z)Trm embryos than in
(Campos-Ortega and Hartenstein, 1997). All embryos are oriented anterior to the left, and po
views (displaying ABD-B expression after the germ band has begun to retract). D and H areE(z)Trm with E(z)63, a protein-null allele (Carrington and Jones, 1996;
Gutjahr et al., 1995), develop into pharate adults that have more severe
trx-like phenotypes (Bajusz et al., 2001) (data not shown). These geno-
types should lack any wild type E(Z) protein (after E(Z) of maternal or-
igin has disappeared) and their PRC2 complexes should contain only
E(Z)Trm mutant protein. However, they are also likely to have fewer
PRC2 complexes in this heteroallelic combination, as indicated by a
~30% reduction in H3K27me3 levels in E(z)63/+heterozygotes
as compared to wild type (Siebold et al., 2010). Despite this,
E(z)Trm/E(z)63 adults have an even higher H3K27me3 level than
E(z)Trm/+heterozygotes and more than 3.5 times that of wild type
controls (Fig. 3A). Rare homozygous E(z)Trm pharate adults that can
arise in some backgrounds were previously reported to have even
more severe trx-like phenotypes than hemizygotes (Bajusz et al.,
2001), suggesting that they may have even higher H3K27me3 levels.
However, these occurred too rarely in our E(z)Trm stock to provide
sufﬁcient material for analysis (seeMaterials andmethods). The pos-
itive correlations between E(z)Trm gene dosage, H3K27me3 levels,
and the severity of trx-like phenotypes strongly suggest that the ele-
vated H3K27me3 level of E(z)Trm mutants is the cause of these
phenotypes.
Consistent with the increased severity of E(z)Trm phenotypes caused
by reducing wild type E(z)+ gene dosage and increasing E(z)Trm gene
dosage, increasing thewild type E(z)+ gene dosage in E(z)Trm heterozy-
gotes, using multiple E(z)+ genomic transgenes, suppresses their trx-
like phenotypes (Fig. 4B) (Bajusz et al., 2001) and also reduces their
elevated H3K27me3 level (Fig. 3B). This suggests that the E(z)Trm
mutant protein competes normally with wild type E(Z) for assembly
into the same PRC2 complexes.
In addition to their elevated H3K27me3 level, E(z)Trmmutants also
have lower levels of both H3K27me2 and H3K27me1 (Figs. 3C, D). As
with H3K27me3, this effect is more pronounced in E(z)Trm/E(z)63
pharate adults. This further suggests that the E(z)Trm mutation alters
E(Z) activity in a way that changes the relative yields of the mono-,
di-, and tri-methyl products of its methyltransferase reactions, favor-
ing formation of H3K27me3 at the expense of H3K27me2 and
H3K27me1 (i.e., by increasing the probability that they will be con-
verted to H3K27me3). It also suggests that at the level of the chromatin
landscape, a substantial amount of the increase in H3K27me3 repre-
sents conversion of sites that are normally marked by H3K27me2 and
H3K27me1 to H3K27me3.
E(z)Trm hemizygous adults also have a lower level of acetylated
H3K27 (~15–24% reduction, Fig. 3E), a modiﬁcation that is highly cor-
related with transcriptionally active genes (Creyghton et al., 2010;
Gatta and Mantovani, 2010; Karlic et al., 2010; Rada-Iglesias et al.,
2011; Schwartz et al., 2010; Zentner et al., 2011). H3K27ac directly
antagonizes methylation of H3K27 by E(Z) at Polycomb target
genes, since methylation and acetylation are alternative, mutuallyn. A–H) ABD-B protein expression in wild type and homozygous E(z)Trm embryos from
ls are similar in wild type and E(Z)Trm homozygous embryos (A vs. E, B vs. F). At stages
wild type embryos (C vs. G, D vs. H). Embryo staging is according to standard method
sterior to the right. A, B, E, and F are lateral views of embryos, while C, and G are dorsal
ventral views (displaying ABD-B expression after the germ band has fully retracted).
Fig. 3. E(z)Trm mutants have increased H3K27me3 levels at the expense of other
H3K27 modiﬁcations. A–E) Quantitative Western analysis of bulk levels of
H3K27me3, H3K27me2, H3K27me1, and H3K27ac in adult ﬂies of the indicated ge-
notypes (see details in the Materials and methods) A) H3K27me3 levels are in-
creased in adult E(z)Trm heterozygotes and further increased in a heteroallelic
combination of E(z)Trm with a “protein-null” allele (E(z)Trm/E(z)63) compared to
wild type ﬂies (O-R). B) Suppression of the elevated H3K27me3 level of E(z)Trm het-
erozygotes by increasing their E(z)+ gene dosage with E(z) transgenes containing a
genomic rescue fragment. C–E) H3K27me2, H3K27me1, and H3K27ac levels are de-
creased in E(z)Trm heterozygotes and in an E(z)Trm heteroallelic combination with
protein-null allele (E(z)Trm/E(z)63). The effects in A, C–E are more pronounced in
the E(z)Trm/E(z)63 than in their sibling E(z)Trm/+heterozygotes. A signiﬁcant differ-
ence of the means between samples is indicated by * or #. The protein-null E(z)63 al-
lele causes a single amino acid substitution of an isoleucine for the initiating
methionine (M1I) and produces no detectable protein (Carrington and Jones, 1996).
Fig. 4.Mutations in esc and Su(z)12 suppress the phenotypes of E(z)Trm. A) Adult ﬂies dis-
playing altered pigmentation of the ﬁfth abdominal segment (A5). Expression of Abd-B in
A5 is normally required for the darker pigmentation of A5. The varying patterns of pig-
mentation indicate differences in the severity of inappropriate silencing of Abd-B expres-
sion. Shown are wild type (O-R), E(z)Trm/+heterozygotes, esc9/+ ; E(z)Trm/+double
heterozygotes and E(z)Trm+/+Su(z)121 double heterozygotes. These double heterozy-
gotes display a nearly wild type pigmentation pattern of A5 and A6. This strong suppres-
sion indicates that the ESC and SU(Z)12 subunits of PRC2 are required for the
manifestation of this E(z)Trm phenotype. B) Quantiﬁcation of the penetrance and expres-
sivity of trithorax-like mutant phenotypes of E(z)Trm heterozygotes, and E(z)Trm heterozy-
gotes in combination with various PcG mutations (described in the Materials and
methods). The mean score for each genotype is indicated by a horizontal line. The stan-
dard deviation is indicated by a vertical bar. The mean scores of the double heterozygotes
are all signiﬁcantly different from that of E(z)Trm/+heterozygotes by t-test (pb0.05). C, D)
QuantitativeWestern analysis of H3K27me3 levels of the ﬂies shown in A. Standard error
is shown, and indicated results are signiﬁcant by t-test, pb0.05. A signiﬁcant difference of
the means between samples is indicated by * or #.
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This reduction in H3K27ac is much more pronounced in E(z)Trm em-
bryos (see below). The lower H3K27ac level in E(z)Trm mutants thus
strongly suggests that at least some of their excess H3K27me3 occurs
at H3K27 sites in chromatin that are normally acetylated and associ-
ated with transcriptionally active Polycomb target genes. It also fur-
ther suggests that the E(Z)Trm mutant enzyme can overcome the
antagonistic activities counterbalancing effects of TRX, CBP, the
H3K27 demethylase UTX, and other TrxG proteins that antagonize
H3K27 trimethylation and promote/maintain H3K27 acetylation andtranscriptionally active chromatin states (Lee et al., 2007; Schwartz
et al., 2010; Smith et al., 2008; Tie et al., 2009).
Other PRC2 subunits are required for the elevated H3K27me3 levels and
phenotypes of E(z)Trm mutants
While E(Z) is the catalytic subunit of PRC2, the intrinsic methyl-
transferase activity of wild type E(Z) is undetectable in the absence
of other PRC2 subunits. Exactly how they stimulate E(Z) activity is
not known, but the binding of both ESC and the SU(Z)12:p55 hetero-
dimer to H3 suggest that stimulation may in part involve stabilizing
253V.A. Stepanik, P.J. Harte / Developmental Biology 364 (2012) 249–258the interaction of E(Z) with H3 and/or favorably positioning H3K27
within the active site for methylation (Ketel et al., 2005; Margueron
et al., 2009; Schmitges et al., 2011; Tie et al., 2007). Given the large in-
crease in H3K27me3 in E(z)Trmmutants, we considered the possibility
that the E(Z)Trm mutant enzyme might be capable of functioning
independently of PRC2 complexes, perhaps resulting in H3K27 tri-
methylation at sites not normally targeted by wild type PRC2
complexes . The suppression of E(z)Trm mutant phenotypes by in-
creased E(z)+ gene dosage already suggested that E(Z)Trm competes
with wild type E(Z) for assembly into the same PRC2 complexes. Fur-
ther evidence was obtained by examining the effects of mutations in
other PRC2 subunits on elevated H3K27me3 levels of E(z)Trmmutants.
Heterozygous escmutations were previously reported to suppress the
phenotypes of E(z)Trm (Bajusz et al., 2001). We conﬁrmed this, and
also observed that a heterozygous mutation in another PRC2 subunit,
SU(Z)12, also suppresses the phenotypes of E(z)Trm mutants. (Figs. 4A,
B). The suppression of trx-like phenotypes in both esc9/+; E(z)Trm/+
and + Su(z)121/E(z)Trm+double heterozygotes is accompanied by a
decrease in the elevated H3K27me3 level seen in E(z)Trm heterozygotes
(Figs. 4C, D). This indicates that the phenotypic effect of E(z)Trm, as well
as the increase in H3K27me3, requires the other PRC2 subunits and that
E(Z)Trm, like wild type E(Z), must be incorporated into PRC2 complexes
to exert its dominant inappropriate silencing effects. This, togetherwith
the apparently normal level of E(Z)Trm mutant protein, also makes it
highly unlikely that the phenotypes of E(z)Trm mutants result from
mis-targeting of E(Z)Trm protein to novel chromatin sites, consistent
with the previously reported observation that the gross localization of
E(Z)Trmmutant protein on polytene chromosomes of the larval salivary
gland appeared normal (Bajusz et al., 2001).
E(z)Trm causes premature accumulation of high levels of H3K27me3
during early embryogenesis
The attenuation of the ABD-B expression in homozygous E(z)Trm
embryos indicates that the impact of the E(Z)Trm mutant enzyme is
evident soon after the normal time of onset of Polycomb silencing.
This, together with the apparent increase in trimethylation efﬁciency
of the mutant enzyme, suggested the possibility that the aberrant si-
lencing phenotypes might originate from premature deposition of
H3K27me3 on Polycomb target genes, possibly even before their ini-
tial transcriptional activation at the time of zygotic genome activa-
tion. H3K27me3 is barely detectable by Western in extracts from
0 to 4 h wild type embryos, but becomes readily detectable in 4–8 h
extracts, i.e., once Polycomb silencing normally becomes required to
maintain repression of the homeotic genes (Tie et al., 2009) (Fig. 5).
This temporal regulation of H3K27me3 accumulation might serve to
prevent premature initiation of Polycomb silencing, allowing sufﬁ-
cient time for robust activation of Polycomb target genes in cells
where they are normally active.
To determine the temporal proﬁle of H3K27me3 accumulation
E(z)Trm embryos, we collected all embryos from heterozygous E(z)Trm/
+parents, which yields a genotypically mixed population of E(z)TrmFig. 5. H3K27me3 accumulates prematurely to high levels in E(z)Trm embryos. A, B) Quantit
ferent stages. To obtain sufﬁcient material for analysis, extracts were prepared from embry
gotes, and TM3 homozygotes) as well as O-R (wild type) control embryos staged as indicathomozygotes, heterozygotes, and wild type embryos in a 1:2:1 ratio.
Given that 25% of these embryos are homozygous for a wild type copy
of E(z), and that only 50% of the third chromosomes in the total embryo
collection carry the E(z)Trm mutation, this will yield an underesti-
mate of the H3K27me3 level that is present in homozygous E(z)Trm
embryos used in Fig. 2, perhaps by two fold or more, and may more
closely reﬂect levels present in heterozygous E(z)Trm embryos. We
have made no attempt to correct for this. Nevertheless, compared
to wild type, a high level of H3K27me3 is present prematurely in ex-
tracts from staged E(z)Trm mutant embryos (Fig. 5A), well before the
ﬁrst signs of inappropriate silencing of Abd-B in cells where it is ini-
tially active. In 0–4 hour E(z)Trm embryos the H3K27me3 level is
more than eight times higher than in wild type embryos. This level
of H3K27me3 already surpasses the highest level reached in late
(16–20 hour) wild type embryos. As in wild type embryos,
H3K27me3 continues to accumulate in E(z)Trm embryos as embryo-
genesis proceeds, and by 16–20 h, after H3K27me3 and H3K27ac
levels have plateaued in wild type embryos (Tie et al., 2009), remains
three times higher than in wild type embryos of the same stage.
These observations strongly suggest that the abnormally high level
of H3K27me3 in 0–4 h E(z)Trm embryos potentiates the subsequent
inappropriate silencing of the Abd-B gene in cells where it is normal-
ly active.
E(z)Trm causes a premature and substantial decrease in H3K27ac in
embryos
In contrast to H3K27me3, H3K27ac is readily detectable in early
(0–4 h) wild type embryo extracts, and its level decreases by more
than half over the course of embryogenesis, as the level of
H3K27me3 increases (Tie et al., 2009). Their reciprocal temporal pro-
ﬁles during embryogenesis suggested the possibility that some of the
H3K27ac in 0–4 h embryos is present on Polycomb target genes
where it might serve to prevent the premature deposition of
H3K27me3, and thereby antagonize silencing (Tie et al., 2009) (see
Discussion). If so, the increased H3K27 trimethylation efﬁciency of
the E(Z)Trm enzyme and the resultant large increase in H3K27me3
in 0–4 h embryos would appear to overcome any such effect. Alterna-
tively, the reciprocal temporal proﬁles of H3K27ac and H3K27me3
during embryogenesis might simply be a coincidence. The increased
H3K27me3 level in E(z)Trm embryos thus provided a means to test
for a possible relationship between H3K27me3 and H3K27ac levels
in the early embryo.
The H3K27ac level in 0–4 h E(z)Trm embryo extracts is less than half
(~43%) that of 0–4 h wild type embryos (Fig. 5B). By 16–20 h, after it
has leveled off in wild type embryos (Tie et al., 2009), E(z)Trm embryos
still have less than 65% of the H3K27ac present in wild type embryos.
This strongly suggests that at least some of the increase in H3K27me3
seen in E(z)Trm embryos occurs at the expense of H3K27ac, i.e., occurs
on some of the same H3K27 sites that are normally acetylated. Interest-
ingly, in contrast to wild type embryos, the level of H3K27ac in E(z)Trm
embryos does not decrease substantially after 0–4 h, yet H3K27me3ation of Western blots of H3K27me3 and H3K27ac levels in Drosophila embryos of dif-
os from the E(z)Trm/TM3 stock (i.e., a 1:2:1 mixture of E(z)Trm homozygotes, heterozy-
ed. All samples were run on a single gel and transferred to a single blot.
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acetylated H3K27 sites that can be methylated by E(Z)Trm are limited
and largely exhausted by 4 h, as might be expected if E(Z)Trm-containing
PRC2 complexes are only targeted to the same sites as wild type PRC2
complexes, i.e., to Polycomb target genes. It also suggests that after 4 h
the increase in H3K27me3 occurs predominantly on H3K27 sites that
contain H3K27me2, H3K27me1 or unmodiﬁed H3K27.
Discussion
Evidence presented here suggests that the trithorax-like phenotypes
of E(z)Trm mutants are due to the substantial bulk increase in
H3K27me3, which leads to inappropriate silencing of Polycomb target
genes in cells where they are normally active. How does this come
about? The suppression of the high H3K27me3 levels of E(z)Trmmutants
by Su(z)12 and esc mutations as well as increased E(z)+ gene dosage
indicates that, like wild type E(Z), the E(Z)Trm mutant protein must be
assembled into PRC2 complexes and that its activity depends on other
PRC2 subunits (Fig. 4, Bajusz et al., 2001). Thismeans that E(Z)Trmmutant
protein is likely to be targeted to the same regions of the genome as wild
type E(Z) and not mistargeted to novel sites. Developmental analysis
indicates that inappropriate silencing of Abd-B in E(z)Trmmutants begins
in early embryogenesis, and is presaged by premature accumulation of
H3K27me3 in early (0–4 h) embryos to much higher levels than in wild
type embryos. Surprisingly, this does not prevent normal initiation of
Abd-B expression on schedule, but appears to potentiate its subsequent
attenuation around the time that Polycomb silencing normally becomes
required.
A recent analysis of the in vitro enzymatic activities of recombi-
nant human PRC2 complexes demonstrated that wild type EZH2 dis-
plays the greatest catalytic efﬁciency for the H3K27monomethylation
reaction and lower efﬁciency for the dimethylation (mono- to di-)
and the trimethylation (di- to tri-) reactions (Sneeringer et al.,
2010). The increase in H3K27me3 at the expense of H3K27me1 and
H3K27me2 in E(z)Trm mutants suggests that the R741K substitution
alters E(Z) catalytic activities to preferentially increase its H3K27 tri-
methylation efﬁciency. The mono- and di-methylation activities
might also be affected, but the reduced steady state levels of
H3K27me1 and H3K27me2 levels must be interpreted cautiously,
since they are also inﬂuenced by presence of the H3K27 demethylase
UTX (Lee et al., 2007; Smith et al., 2008) and since some H3K27me1
may be produced by another methyltransferase besides E(Z) (Wu et
al., 2011).
The decrease in H3K27ac also indicates that not all of the increase
in H3K27me3 occurs at the expense of H3K27me1/2. The reduced
level of H3K27ac in E(z)Trm mutants, a modiﬁcation that directly an-
tagonizes H3K27 methylation, strongly suggests that at least some
of the increase in H3K27me3 occurs at the expense of H3K27ac, i.e.,
occurs at H3K27 sites that are normally acetylated and associated
with transcriptionally active Polycomb target genes. Indeed, in the
absence of direct evidence that the excess H3K27me3 in E(z)Trm mu-
tants occupies genomic sites of normally active Polycomb target
genes, the lower level of bulk H3K27ac is perhaps the strongest evi-
dence that the elevated H3K27me3 level in E(z)Trm mutants is the
cause of the inappropriate silencing of normally active Polycomb tar-
get genes.
The nature of the E(z)Trm mutation
The R741K substitution occurs in a region of the catalytic SET do-
main of E(Z) that plays an important role in the methyltransferase ac-
tivity of other SET domain proteins. The adjacent Y740 residue is
invariant in all SET domain proteins. Mutating the corresponding ty-
rosine to alanine in SET7/9 or to phenylalanine in DIM-5 all but elim-
inates the methyltransferase activity of these proteins (Wilson et al.,
2002; Zhang et al., 2002). A structural study showed that thisconserved tyrosine is positioned in close proximity to the substrate
lysine targeted for methylation (Zhang et al., 2003). Residue Y742 is
also invariant in E(Z) orthologs (Fig. 1), though it varies among
other SET domain proteins. The residue present at the corresponding
position in the H3K9 trimethylase DIM-5 is involved in recognition of
the substrate peptide (Zhang et al., 2003).
Of particular relevance to the current work are several structure-
based in vitro mutagenesis studies of other SET domain proteins
that identiﬁed a “phenylalanine/tyrosine switch” that affects the
number of methyl groups the enzymes can add to the substrate ly-
sine. This “switch” affects the residue corresponding to F738 in E(Z).
Mutating the phenylanine present at this position to the bulkier tyro-
sine in the H3K9 trimethylases DIM-5 and G9a results in enzymes
that can only catalyze mono- and dimethylation (Collins et al.,
2005; Zhang et al., 2003). Conversely, mutating the tyrosine present
at this position to phenylalanine in the H4K20 monomethylase SET8
allows the enzyme to add a second methyl group to H4K20 (Zhang
et al., 2003).
The results of these studies suggest that the E(Z)Trm R741K substi-
tution may increase trimethylation efﬁciency by altering the dimen-
sions of the catalytic pocket either directly, via its more compact
side chain, or by altering the positioning of the adjacent Y740, Y742,
F738 or other residues that affect the catalytic pocket of E(Z). This
could occur by altering the rate of the reaction, the afﬁnity of E(Z)
for the substrates of the methyltransferase reaction, enhancing the
release of products of the reaction, or by enabling the enzyme to bet-
ter accommodate the bulkier products of the trimethylation reaction.
Recently, a number of other dominant mutations in human EZH2
that cause elevated H3K27me3 levels have been detected in follicular
lymphomas and diffuse-large B-cell lymphomas, always in heterozy-
gous condition (Morin et al., 2010). These recurring mutations, single
amino acid substitutions for Y641 (Y655 in E(Z)), a conserved residue
in the SET domain, were found to have increased H3K27 di- and tri-
methylation activity but no monomethylation activity, explaining
their obligate heterozygosity for manifestation of their elevated
H3K27me3 phenotype. In contrast, the E(Z)Trm mutant enzyme pro-
duces a higher H3K27me3 level in the absence of wild type protein
than when heterozygous, indicating that the R741K substitution
does not abolish monomethylation activity.
The origin of inappropriate silencing in early embryogenesis in E(z)Trm
mutants
Remarkably, 0–4 h E(z)Trm embryos exhibit an 8-fold increase in
bulk H3K27me3 and a greater than 55% reduction in the level of
H3K27ac (Fig. 5B). This suggests that if the H3K27ac present in
early embryos normally plays a role in preventing the premature
onset of H3K27 trimethylation, the increased trimethylation efﬁcien-
cy of E(Z)Trm is sufﬁcient to overcome it. It further suggests that de-
spite the very low level of H3K27me3 in 0–4 h wild type embryos,
the PRC2 subunits that are already present in the nuclei of early cleav-
age stage embryos (Carrington and Jones, 1996; Gutjahr et al., 1995)
are likely to be assembled into enzymatically active PRC2 complexes.
In spite of the much higher H3K27me3 level in 0–4 hour E(z)Trm
embryos, the levels of ABD-B in E(z)Trm and wild type embryos are in-
distinguishable until after completion of germ band elongation, i.e.,
after the time when Polycomb silencing of the homeotic genes is nor-
mally established (Fig. 2). This indicates that while H3K27me3 is re-
quired for Polycomb silencing, the elevated H3K27me3 level in
0–4 hour E(z)Trm embryos does not, by itself, exert a “repressive” ef-
fect on early Abd-B expression or advance the time of onset of Poly-
comb silencing. Thus, some other factor or signal that is required for
Polycomb silencing must be absent or inactive during this early
stage. This might include, for example, a developmentally pro-
grammed delay in the maturation of functionally active PRC1 com-
plexes, which bind to H3K27me3-containing nucleosomes produced
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lencing. Whatever the nature of this limiting factor/signal, once Poly-
comb silencing begins, the premature accumulation of H3K27me3
appears to “predestine” or potentiate the inappropriate silencing of
already activated Polycomb target genes.
Does the E(z)Trm mutation implicate deacetylation of H3K27ac in
establishment of Polycomb silencing?
Interestingly, Bajusz et al. (2001) observed that feeding the his-
tone deacetylase inhibitor sodium butyrate to E(z)Trm/+females par-
tially suppressed the trx-like phenotypes of their E(z)Trm/+progeny,
suggesting that a deacetylase activity may be required during early
embryogenesis for these phenotypes to develop. Our observation
that during embryogenesis, H3K27ac levels are highest in 0–4 h
wild type embryos (Tie et al., 2009) (Fig. 5), but are more than 55%
lower in 0–4 h E(z)Trm embryos is consistent with the possibility
that it is speciﬁcally the inhibition of H3K27ac deacetylation by ma-
ternal butyrate feeding that suppresses the development of trx-like
phenotypes in E(z)Trm mutants, indirectly inhibiting the premature
accumulation of high levels of H3K27me3 by helping to maintain
H3K27ac. The histone deacetylase RPD3/HDAC1 has been implicated
in H3K27ac deacetylation in vivo by RNAi knockdown in Drosophila
S2 cells (Tie et al., 2009). RPD3 is physically associated with PRC2
and PRC1 complexes in both Drosophila and mammals (Chang et al.,
2001; Kuzmichev et al., 2002; Saurin et al., 2001; Tie et al., 2001,
2003; van der Vlag and Otte, 1999) and is required in vivo for robust
Polycomb silencing (Chang et al., 2001; Tie et al., 2001). RPD3 of ma-
ternal origin is already present in the early embryo, and is presum-
ably available to deacetylate H3K27 (Chen et al., 1999). Our results,
together with those of Bajusz et al. (2001), thus suggest that the ini-
tial establishment of Polycomb silencing during normal development
may require active deacetylation of preexisting H3K27ac as a prereq-
uisite to at least some H3K27 trimethylation.
Mechanism of E(Z)Trm action
If the H3K27ac already present in 0–4 h embryos normally plays a
role in inhibiting the premature accumulation of H3K27me3, then the
effect of the E(z)Trm mutation on the H3K27ac level indicates that the
mutant enzyme can override this inhibition. How could it do this? It
seems unlikely that simply altering the H3K27 trimethylation efﬁ-
ciency of E(Z) would lead to increased H3K27ac deacetylation activi-
ty. Instead, we speculate that the higher trimethylation efﬁciency of
the E(Z)Trm mutant enzyme alters an ongoing dynamic balance be-
tween H3K27 acetylation/deacetylation and methylation/demethyla-
tion activities in the early embryo. It was recently shown that the
CBP-mediated acetylation of H3K4me3-containing nucleosomes is
highly dynamic and its dynamic nature is critical for transcriptional
activation (Crump et al., 2011). The physical association of E(Z) and
RPD3 likely increases the efﬁciency of the sequential deacetylation
and methylation reactions required for replacement of an H3K27ac
with H3K27me3, a possible advantage for efﬁcient developmentally
programmed switching from a transcriptionally active to silent
state. This suggests that with no change in an already dynamic acety-
lation–deacetylation cycle, the presence of E(Z)Trm would further in-
crease the probability that an un/deacetylated H3K27 will be
methylated before it can be (re)acetylated, and would have the cu-
mulative effect of increasing the bulk H3K27me3 level at the expense
of H3K27ac, as observed.
To gain further insight into how E(z)Trm promotes inappropriate
silencing of normally active Polycomb target genes, it will be impor-
tant to determine the effect of E(z)Trm on the genome-wide distribu-
tions of H3K27me3/2/1 and H3K27ac, as well as PcG and TrxG
proteins. Understanding the effects of E(z)Trm in further detail could
provide new insights into the role of aberrant Polycomb silencing incancer. In addition to the above EZH2 mutations with increased
H3K27 trimethylation activity in B cell lymphomas, EZH2 and other
PRC2 subunits have been found to be overexpressed in many solid tu-
mors (Bracken and Helin, 2009; Chase and Cross, 2011; Margueron
and Reinberg, 2011; Simon and Lange, 2008), leading to aberrant
H3K27 trimethylation and silencing of tumor suppressor genes
(Margueron and Reinberg, 2011). The level of overexpression is pos-
itively correlated with poor prognosis (Chase and Cross, 2011) and
RNAi knockdown of elevated EZH2 levels in can halt tumor cell
proliferation (Varambally et al., 2002). While the mechanisms under-
lying inappropriate silencing due to EZH2 overexpression and due to
E(Z)Trm and other hyper-trimethylating mutants are likely to differ,
they underscore the importance of understanding how TRX, CBP,
UTX and other TrxG factors antagonize H3K27 methylation by PRC2
to prevent inappropriate silencing of normally active Polycomb target
genes and maintain their active states. Further understanding of how
E(z)Trm overrides their antagonistic activities should provide addi-
tional insights into how they do so.
Materials and methods
Drosophila strains
The E(z)Trm, the Su(z)121 and esc9mutationswere kindly provided by
Henrik Gyurkovics, Asa Rasmuson-Lestander and Gary Struhl,
respectively. The E(z)+ “rescue” line, P[(ry+, B)2]; P[(ry+, B)23]ry,
which is homozygous for two different insertions of a genomic E(z)+
transgene, on the second and third chromosomes respectively, was
kindly provided by Richard Jones (Jones and Gelbart, 1993). E(z)63 is an
EMS-inducedpointmutation that results in a substitution of an isoleucine
for the initiating methionine (M1I) and is protein-null (Carrington and
Jones, 1996; Jones and Gelbart, 1990). esc9 (Gutjahr et al., 1995) is an
EMS-induced dominant negative allele that disrupts a WD motif of ESC
(M236K) (Sathe and Harte, 1995). Similar results were seen with esc6
(not shown). Su(z)121 is loss of function allele resulting from a P-
element insertion into codon 564 of Su(z)12, which is therefore likely to
produce a truncated or unstable protein (Birve et al., 2001). Similar re-
sults were observed with the Su(z)124 allele (not shown).
The E(z)Trm stock used for the original genetic analysis (Bajusz
et al., 2001) was reported to occasionally produce fully developed
pharate adult E(z)Trm homozygotes, which have considerably more
extreme trx-like phenotypes than hemizygotes (which in turn are
more extreme than heterozygotes). After out-crossing E(z)Trm hetero-
zygotes for more than ten generations into a wild type Oregon-R or
Canton-S backgrounds and establishing new balanced stocks, we
were unable to recover any homozygous E(z)Trm pharate adults. Near-
ly all E(z)Trm homozygous embryos hatched from the egg into ﬁrst in-
star larvae. Occasional homozygotes survived to third instar, but most
died in ﬁrst or second instar. After keeping a stock for many genera-
tions, it could produce rare homozygous pharate adults, consistent
with the previous observation that phenotypes became less severe
and were lost over time, presumably due to the accumulation of mod-
iﬁers (Bajusz et al., 2001).
Evaluation of trxG phenotypes
The following metric was used to evaluate the penetrance and ex-
pressivity of the trithorax-like phenotypes of E(z)Trm mutant adults,
with the possible score on a single male ﬂy in parentheses: loss of
A5 pigmentation (score=0–4, based on severity of phenotype), ec-
topic T1 sternopleural bristles (score=0–2, x 2 possible ectopic
patches), ectopic T3 sternopleural bristles (score=0–2, x 2 possible
ectopic patches), haltere to wing (score=0–2, x 2 halteres), ectopic
apical bristles on L1 (0–4 bristles), ectopic apical bristles on L3 (0–4
bristles), ectopic mesosternal bristles on T3 (0–2 bristles),
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(score=0–1, x 2 L1 legs). The maximum possible score was 29.
Preparation of extracts for analysis of histones
For each genotype analyzed, 50 adult males were homogenized in
a 2 ml dounce with 400 μl of ice cold Buffer W (10 mM Tris pH 7.4,
13 mM EDTA, 1 mM DTT) containing Complete protease and Phos-
Stop phosphatase inhibitors (Roche), and 50 mM sodium butyrate
(Sigma). Extracts were spun at 7500 rpm for 10 min. The insoluble
material was washed with Buffer W, then resuspended in 400 μl
fresh 1× SDS sample buffer containing 50 mM sodium butyrate and
incubated at 95 °C for 5 min with occasional mixing. The extract
was spun at 12,000 rpm for 10 min to remove insoluble debris then
the supernatant was removed and spun again. Approximately 7 μl of
a 1:2 dilution of the supernatant was then examined by quantitative
Western.
For experimental and control lanes in Fig. 3, 50 pharate adult
males in their pupal cases were used, since E(z)Trm/E(z)63 hemizy-
gotes did not survive past that stage. Histones were prepared as de-
scribed above for adults.
For examination of histones from embryonic stages, nuclei from
staged embryos were isolated by dounce homogenization, followed
by lysis of nuclei as previously described (Tie et al., 1998). Insoluble
material was resuspended in 1× SDS sample buffer containing inhib-
itors, as above. Extracts were adjusted to have equivalent H3 concen-
trations before quantitative analysis.
Quantitative Western analysis of histone posttranslational modiﬁcations
For adult and pharate adult extracts, three independent replicates
of the indicated genotypes and timepoints were run on a single 13%
SDS gel, and proteins were transferred to a single 0.2 μm Odyssey ni-
trocellulose membrane (Li-Cor 926–31092) in 25 mM CAPS, pH 10.0,
with 20% methanol. For developmental Westerns, three independent
replicates of all time points were done and yielded similar results. For
each of two of these replicates, all time points for E(z)Trm and wild
type control genotypes were run on a single gel. Fig. 5 shows repre-
sentative results from one of these blots. For a third replicate, each
of the three time points for both genotypes were run separately on
three gels. For all other experiments, three replicates of each indicat-
ed genotype were run on a single gel and transferred to a single blot.
Blots were blocked in ECL Plex blocking buffer (G.E.) for 1 h, then in-
cubated with the indicated α-histone antibodies at 4 °C for approxi-
mately 40 h, and then incubated with the appropriate Cy5-labeled
secondaries (Millipore) for 1 h. Individual histone modiﬁcation levels
were then quantiﬁed on a G.E. Typhoon Trio at 50 micron resolution
using the Imagequant TL 7.0 software package. Blots were then
stripped for 15 min in 0.1 M NaOH, reblocked, and incubated with
α-H3 antibodies for approximately 40 h. The total H3 level was quan-
tiﬁed using a Cy3-labeled secondary antibody. The relative amount of
each histone modiﬁcation in different samples was obtained by nor-
malizing to the total H3 level in each sample. Some experimental var-
iation in the H3K27me3 differential between wild type and E(z)Trm
ﬂies was seen depending on the lots of α-H3K27me3 used (e.g.,
Figs. 3 and 4), or the amount of protein loaded. Efforts were made
to load equal amounts of H3 for all samples.
Immunostaining of Drosophila embryos
Since adult E(z)Trm homozygotes havemore extreme trx-like phe-
notypes than both hemizygotes and heterozygotes (Bajusz et al.,
2001), we examined staged embryos homozygous for E(z)Trm to de-
termine when ABD-B expression becomes abnormal. Embryos were
stained according to a standard protocol, and were ﬁxed for 20 min
with 1.6% formaldehyde at room temperature (Sullivan et al.,2000). Primary antibodies were added at a 1:100 (α-ABD-B) to
1:500 (α-β-Gal) dilution and incubated on a nutator overnight at
4 °C. Following washes, FITC- or Cy5-labeled secondaries were
added at a 1:1000 dilution and incubated for 2 h. Embryos were
then washed, mounted, and imaged. E(z)Trm was balanced with
TM3 containing a lacZ reporter transgene driven by the ftz promoter.
E(z)Trm homozygotes were identiﬁed by the absence of β-Gal immu-
nostaining. Although most E(z)Trm/E(z)Trm (i.e., lacZ negative) em-
bryos showed reduced ABD-B at the stages noted, in a minority
(~10–20%) of embryos the ABD-B expression appeared to be near
wild type levels, possibly reﬂecting variation in the expressivity of
the E(z)Trm mutant phenotype, variation in the time of onset of re-
duced ABD-B expression, or false negative lacZ staining. Approxi-
mately 20–25 embryos of each genotype at the indicated time
points were compared. At the stages examined, the ABD-B level in
heterozygous E(z)Trm/TM3 embryos (i.e., E(z)Trm/+) appeared to be
normal compared to homozygous E(z)Trm embryos. This is most like-
ly attributable to a lower level of H3K27me3 in E(z)Trm heterozygotes
than in homozygotes.
Antibodies
The following antibodies were used: α-H3K27me3 (Upstate
07–449), α-H3K27me2 (Upstate 07–452), α-H3K27me1 (Upstate
07–448), α-H3K27ac (Abcam4729), α-H3 (Abcam 12079), and α-β-
Gal (0856033, MP Biomedicals). The α-ABD-B monoclonal antibody
1A2E9 (Celniker et al., 1989; Simon et al., 1992) was obtained from
the Developmental Studies Hybridoma Bank, Iowa City, Iowa.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.12.007.
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